This randomized, placebo-controlled trial tested whether arthroscopic lavage or débridement actually improves pain and function in knee osteoarthritis — or whether the reported benefit in prior studies was a placebo effect. 180 patients were assigned to débridement, lavage, or a sham procedure with skin incisions only. Outcomes were tracked across six pain and function scales over 24 months.
The key number to internalize: at 2 years, pain scores differed by less than 2 points on a 100-point scale between sham surgery and both real procedures. The confidence intervals didn't just fail to show superiority — they excluded any clinically meaningful benefit. That is a stronger statement than a simple null result.
This is why current guidelines do not support arthroscopic lavage or débridement for primary knee OA. When a patient asks about "cleaning out" their arthritic knee, this trial is the answer: the improvement people felt in prior studies came from placebo response and natural disease fluctuation, not from the procedure itself.
The one procedural exception the authors built into the protocol matters clinically: a displaced bucket-handle meniscal tear encountered during lavage was still treated. The trial is about OA management, not about leaving mechanically unstable tears untreated.
For the boards, understand what this trial does and does not say. It applies to patients with OA as the primary diagnosis. It does not address arthroscopy for mechanical symptoms (locked knee, unstable meniscal tear) in a patient who also has incidental OA — that distinction drives the clinical decision.
This randomized, placebo-controlled trial tested whether arthroscopic lavage or débridement actually improves pain and function in knee osteoarthritis — or whether the reported benefit in prior studies was a placebo effect. 180 patients were assigned to débridement, lavage, or a sham procedure with skin incisions only. Outcomes were tracked across six pain and function scales over 24 months.
The key number to internalize: at 2 years, pain scores differed by less than 2 points on a 100-point scale between sham surgery and both real procedures. The confidence intervals didn't just fail to show superiority — they excluded any clinically meaningful benefit. That is a stronger statement than a simple null result.
This is why current guidelines do not support arthroscopic lavage or débridement for primary knee OA. When a patient asks about "cleaning out" their arthritic knee, this trial is the answer: the improvement people felt in prior studies came from placebo response and natural disease fluctuation, not from the procedure itself.
The one procedural exception the authors built into the protocol matters clinically: a displaced bucket-handle meniscal tear encountered during lavage was still treated. The trial is about OA management, not about leaving mechanically unstable tears untreated.
For the boards, understand what this trial does and does not say. It applies to patients with OA as the primary diagnosis. It does not address arthroscopy for mechanical symptoms (locked knee, unstable meniscal tear) in a patient who also has incidental OA — that distinction drives the clinical decision.